Limitations of biopsy Gleason grade: Implications for counseling patients with biopsy Gleason score 6 prostate cancer

Journal of Urology

Volumn 172, Issue 1, 2004, Pages 98-102

  Sved, Paul D ^a   Gomez, Pablo ^a   Manoharan, M ^a   Kim, Sandy S ^a   Soloway, Mark S ^a,b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b Department of Urology ^*  (United States)

Author keywords

Biopsy; Prognosis; Prostate; Prostatectomy; Prostatic neoplasms

Indexed keywords

CANCER RECURRENCE; CONFERENCE PAPER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; NEEDLE BIOPSY; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; RETROSPECTIVE STUDY; SEMINAL VESICLE; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; LYMPH NODE METASTASIS; MIDDLE AGED; PATHOLOGY; PROSTATE TUMOR; PROSTATECTOMY; TUMOR RECURRENCE;

AGED; BIOPSY, NEEDLE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; SEMINAL VESICLES;

EID: 3242791771     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000132135.18093.d6     Document Type: Conference Paper

References (20)

1. Scherr, D., Swindle, P. W., Scardino, P. T. and National Comprehensive Cancer Network: National Comprehensive Cancer Network guidelines for the management of prostate cancer. Urology, suppl., 61: 14, 2003
2. Cookson, M. S., Fleshner, N. E., Soloway, S. M. and Fair, W. R.: Correlation between Gleason score of needle biopsy and radical prostatectomy specimen: accuracy and clinical implications. J Urol, 157: 559, 1997
3. Steinberg, D. M., Sauvageot, J., Piantadosi, S. and Epstein, J. I.: Correlation of prostate cancer biopsy and radical prostatectomy Gleason grade in academic and community settings. Am J Surg Pathol, 157: 566, 1997
4. Thickman, G. D., Spears, W. C., Philpott, P. J. and Shapiro, H.: Effect of the number of core biopsies of the prostate on predicting Gleason score on prostate cancer. J Urol, 156: 110, 1996
5. Carlson, G. D., Calvanese, C. B., Kahane, H. and Epstein, J. I.: Accuracy of biopsy Gleason scores from a large uropathology laboratory: use of a diagnostic protocol to minimize observer variability. Urology, 51: 525, 1998
6. Lattouf, J. B. and Saad, F.: Gleason score on biopsy: is it reliable for predicting the final grade on pathology? BJU Int, 90: 694, 2002
7. Walsh, P. C.: Anatomic radical prostatectomy: evolution of the surgical technique. J Urol, 160: 2418, 1998
8. Soloway, M. S. and Neulander, E.: Bladder-neck preservation during radical retropubic prostatectomy. Semin Urol Oncol, 18: 51, 2000
9. Manoharan, M., Civantos, F., Kim, S. S., Gomez, P. and Soloway, M. S.: Visual estimate of percent of carcinoma predicts recurrence after radical prostatectomy. J Urol, 170: 1194, 2004
10. Arming, C. L., Bergstrahl, E. J., Blute, M. L., Sleezak, J. M. and Zincke, H.: Defining prostate specific antigen progression after radical prostatectomy: what is the most appropriate cut point? J Urol, 165: 1146, 2001
11. Carter, H. B., Walsh, P. C., Landis, P. and Epstein, J. I.: Expectant management of nonpalpable prostate cancer with curative intent: preliminary results. J Urol, 167: 1231, 2002
12. San Francisco, I. F., DeWolf, W. C., Rosen, S., Upton, M. and Olumi, A. F.: Extended prostate needle biopsy improves concordance of Gleason grading between prostate needle biopsy and radical prostatectomy. J Urol, 169: 136, 2003
13. King, C. R. and Long, J. P.: Prostate biopsy grading errors: a sampling problem? Int J Cancer, 90: 326, 2000
14. Freedland, S. J., Aronson, W. J., Csathy, G. S., Kane, C. J., Amling, C. L., Presti, J. C., Jr. et al: Comparison of percentage of total prostate needle biopsy tissue with cancer to percentage of cores with cancer for predicting PSA recurrence after radical prostatectomy: results from the SEARCH database. Urology, 61: 742, 2003
15. Epstein, J. I., Pizov, G. and Walsh, P. C.: Correlation of pathologic findings with progression after radical retropubic prostatectomy. Cancer, 71: 3582, 1993
16. D'Amico, A. V., Whittington, R., Malkowicz, S. B., Schultz, D., Blank, K., Broderick, G. A. et al: Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA, 280: 969, 1998
17. Nag, S., Beyer, D., Friedland, J., Grimm, P. and Nath, R.: American brachytherapy society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer. Int J Radiat Oncol Biol Phys, 44: 789, 1999
18. D'Amico, A. V., Schultz, D., Loffredo, M., Dugal, R., Hurwitz, M., Kaplan, I. et al: Biochemical outcome following external beam radiation therapy with or without androgen suppression therapy for clinically localized prostate cancer. JAMA, 284:1280, 2000
19. Sofer, M., Hamilton-Nelson, K. L., Civantos, F. and Soloway M. S.: Positive surgical margins after radical retropubic prostatectomy: the influence of site and number on progression J Urol, 167: 2453, 2002
20. Narayan, P., Jajodia, P., Stein, R. and Tanagho, E. A.: A comparison of fine needle aspiration and core biopsy in diagnosis and preoperative grading of prostate cancer. J Urol, 141: 560 1989